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Abstract
Objective: To assess changes in the prevalence of HIV and other sexually transmitted infections, as well as in different
proximal and distal factors related to HIV infection, in the general population of Cotonou between 1998 and 2008, while an
intensive preventive intervention targeting the sex work milieu was ongoing.
Methods: A two-stage cluster sampling procedure was used to select the participants in each study. Subjects aged 15–49
who agreed to participate were interviewed and tested for HIV, syphilis, HSV-2, gonorrhoea and chlamydia. We used the
Roa-Scott Chi-square test (proportions) and the Student’s t test (means) for bivariate comparisons, and adjusted logistic
regression models taking into account the cluster effect for multivariate analyses.
Results: HIV prevalence decreased significantly in men (3.4% in 1998 versus 2.0% in 2008, p = 0.048), especially in those
aged 15–29 (3.0% to 0.5%, p = 0.002). Among men, the prevalence of gonorrhoea decreased significantly (1.1% to 0.3%,
p = 0.046) while HSV-2 prevalence increased from 12.0% to 18.1% (p = 0.0003). The proportion of men who reported
condom use at least once (29.3% to 61.0%, p,0.0001) and of those having attained a secondary educational level or more
(17.1% to 61.3%, p,0.0001) also increased significantly. There was an overall decrease in the prevalence of syphilis (1.5% to
0.6%, p = 0.0003).
Conclusion: This is the first population-based study reporting a significant decline in HIV prevalence among young men in
an African setting where overall prevalence has never reached 5%. The decline occurred while preventive interventions
targeting the sex work milieu were ongoing and the educational level was increasing.
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Introduction
Sub-Saharan Africa is still severely affected by the HIV
epidemic. While accounting for only 12% of the world population,
68% of the 34 million people infected with HIV worldwide live in
this region [1]. A recent analysis mainly using data from antenatal
care attendees provided some evidence of a significant decline in
HIV prevalence between 2000 and 2010 in several African
countries [1]. Only a few population-based studies documented a
decline in HIV prevalence in the general population of some
African countries. Such a decline was mainly observed among
young people in Eastern and Southern Africa countries with highly
generalized epidemics. In Eastern Zimbabwe between 1998 and
2003, HIV prevalence significantly decreased by 23% (10.6% to
8.1%) among more educated men aged 17–29 years [2]. Between
2000 and 2008, in Botswana, South Africa and the United
Republic of Tanzania, national population-based surveys showed
a significant decline of 25% or more in HIV prevalence among
young men with concomitant changes in HIV related risky
behaviour [3]. In West Africa, no decline in HIV prevalence
among young people was documented through population-based
surveys. However, in the general population of Coˆte d’Ivoire, a
decline in HIV prevalence was observed between 1989 (7.0%) [4]
and 2005 (4.7%) [5] in adults (15–45 years of age) living outside
Abidjan. This observation was however made using the data of
two entirely independent studies not using the same methodology
and without the same population coverage. In Mali and Niger, two
Demographic and Health Surveys (DHS) conducted in 2001 and
2006 have shown low (between 0.4 and 0.9%) and stable HIV
prevalence among young men [6–9]. In Benin, HIV prevalence in
the adult general population was 1.2% in 2006 [10]. In this
country as elsewhere in sub-Saharan Africa, HIV transmission is
predominantly heterosexual [11] and, as in most West African
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countries, the epidemic is concentrated among female sex workers
(FSWs) and their clients [12]. Specific preventive interventions
targeting both groups have the potential to substantially reduce
HIV transmission over time, first among themselves and then
among the general population [13–16]. Accordingly, in 1992 the
Canadian International Development Agency (CIDA) funded an
intervention for FSWs involving fully integrated field outreach
activities (including behavioural change communication, improved
condom accessibility and promotion of correct condom use),
routine check-ups and free treatment of sexually transmitted
infections (STI) at a clinic dedicated to FSWs. The intervention
was implemented in Cotonou, the largest city and economic
capital of Benin. It was extended to six other cities and to the
clients of FSWs from year 2000. The interventions with clients
consisted in outreach activities coupled with referral to free and
confidential STI clinics for men. Overall the intervention was
followed by declines in HIV and STI prevalence among the FSWs
and their clients [13,15]. Since data from population-based HIV
seroprevalence surveys are more accurate in estimating HIV
prevalence in the general population than data from antenatal
clinics (ANC) [17] and as part of a broader project aiming at
evaluating the overall impact of FSW preventive interventions, we
conducted a cross-sectional study of HIV/STI prevalence and
sexual behaviour in the general population of Cotonou in 2008.
The aim of the present study was to compare data on HIV/STI
prevalence from the latter study with data collected in a previous
cross-sectional study carried out in 1998 [18], in order to assess the
change in the prevalence of HIV and other STI, as well as in
different proximal and distal factors related to HIV infection, in
the general population of Cotonou.
Methods
Sampling, Recruitment and Data Collection
During the studies conducted in 1998 and 2008, there were
approximately 650,000 and 808,000 inhabitants in Cotonou,
respectively [19]. A two-stage cluster sampling procedure was used
to select the participants in both studies: the census areas were first
selected using a probability proportional to size method and fixed
number of households were then randomly selected from each
census area [18]. In 1998 and 2008, respectively 950 and 1,070
households were sampled from 38 census areas. The selected
households were visited and all the residents (women and men)
aged 15–49 years were asked to participate in the studies. After
being pre-tested and modified accordingly, structured, gender-
specific questionnaires previously validated by the Joint United
Nations Programme on HIV/AIDS (UNAIDS) were used to
collect information on socio-demographic characteristics, condom
use and sexual behaviour [20]. All the participants were asked to
provide a blood sample to test for HIV, syphilis and herpes
simplex virus type 2 (HSV-2) antibodies. A urine sample was
collected to test for Neisseria gonorrhoeae (NG) and Chlamydia
trachomatis (CT). A vaginal swab for Trichomonas vaginalis (TV)
diagnosis was obtained from women. In 2008, dried blood spot
(DBS) samples for HIV testing were obtained from participants
who refused venipuncture, but who agreed to provide capillary
blood. In participants who refused any blood collection, the urine
Figure 1. Univariate comparison of HIV/STI prevalence between 1998 and 2008 among women, Men and Overall, aged 15–49 years,
general population of Cotonou, Benin. P-values are from Roa-Scott chi-square tests (chi-square tests adjusted for the cluster effect). NG,
Neisseria gonorrhoeae; CT, Chlamydia trachomatis; TP, Treponema pallidum; HSV-2, Herpes simplex virus type-2.
doi:10.1371/journal.pone.0043818.g001
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sample was used for HIV testing, if consent was given for this
procedure. The collection of specimens and the interviews were
carried out in the participants’ houses.
Laboratory Procedures
In 1998, HIV was tested with an enzyme-linked immunoassay
(EIA; ICE HIV1/2; Murex Diagnostics, Dartford, UK) and
confirmed with a rapid test (Capillus HIV1/2; Cambridge
Diagnostics, Galway, Ireland). In 2008, two EIAs were used:
Vironostika HIV1/2 (Biome´rieux, Nancy, France) confirmed with
Genie IIH HIV1/2 (Bio-Rad, Marnes-la-Coquette, France) for
both the serum and DBS samples. In 2008, for participants who
provided only urine samples for HIV testing, the first test was an
EIA (Calypte Biomedical Corporation, Berkeley, California,
USA), followed by Western Blot (Calypte Biomedical Corpora-
tion’s Cambridge Biotech Co., Worcester, Mass) confirmation.
Quality control for HIV testing was carried out on all the positive
tests and 2% of the negative ones [21]. For HSV-2, serum samples
were tested with two different HSV-2 Type Specific IgG ELISAs
(Gull Laboratories, Bad Homburg, Germany in 1998 and Kalon
Biological, Surrey, United Kingdom in 2008), since the Gull test
(used in 1998) was withdrawn from the market before 2001 [22].
Syphilis diagnosis on serum samples was based on the same tests in
both rounds: a positive rapid plasma reagin (RPR) Card Antigen
Suspension (Becton Dickinson & Co., Cockeysville, Maryland,
USA) confirmed by a positive Treponema pallidum particle aggluti-
nation (TPPA; Fujirebio Inc, Tokyo, Japan) [18]. Urine samples
were tested for NG/CT using DNA amplification methods
(Amplicor NG/CT Test, Roche Diagnostics, Branchburg, New
Jersey, USA). Positive samples were confirmed with the LCxTM
NG/CT Assay (Abbott Laboratories, Chicago, Illinois, USA) in
1998 and the BD ProbeTec CT/NG (Becton Dickinson & Co.,
Cockeysville, Maryland, USA) in 2008. Finally, for TV diagnosis
in women, a culture using the InPouchTM TV (Biomed
Diagnostics, San Jose´, California, USA) was used during both
rounds.
Statistical Analyses
Data were double-entered with EPI-INFO (CDC, Atlanta,
Georgia, USA) and analysed with SAS 9.2 (SAS Institute, Inc.,
Cary, North Carolina). Descriptive comparisons of socio-demo-
graphic, sexual behaviour and laboratory variables using the Roa-
Scott Chi-square test (proportions) or the t-test (means), taking into
account the cluster effect, were performed to compare participants
in both studies. Changes in HIV/STI prevalence were described
after stratification for age and gender. Multivariate logistic
regression models (taking into account the cluster effect and
adjusting for socio-demographic variables) were performed for the
analyses of HIV/STI trends. Finally, using identical multivariate
logistic regression and the pooled data (1998 and 2008), we
assessed the association between HIV prevalence and the main
socio-demographic and behavioural factors collected in both study
rounds for all respondents and then separately for men and
women (three different models are presented). We also systemat-
ically considered the statistical interaction between the study
round and factors significantly associated with HIV. Where this
interaction is significant, the association between the risk factor
and HIV is presented separately for each round. Adjusted odds
ratios with their 95% confidence intervals were computed for all
the variables kept in the model (all factors statistically significant at
a 0.05 two-tailed alpha threshold in at least one of the models were
kept in the three final models) and a test for trend was carried out
for variables with multiple ordered categories.
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Ethical Considerations
Verbal informed consent was obtained from all the selected
participants (separately for the interview and for each biological
specimen). Verbal consent was preferred to written consent to
ensure full anonymity of the participants on all documents related
to the study in the context of HIV-related stigma. In 1998, the
verbal consent was documented on the consent forms by the
signature of the interviewer, whereas a witness, completely
independent of the study staff, confirmed in writing the verbal
consent of the participant in 2008. Signed consent forms were kept
along with the questionnaires and a copy was given to each
participant. Both studies, including the consent procedures and
forms, were approved by an ad hoc ethics committee convened by
the Ministry of Health in Benin and the Institutional Review
Board (IRB) of the Institute of Tropical Medicine (Antwerp,
Belgium). Additional approval was obtained from the ethics
committee of the London School of Hygiene and Tropical
Medicine in 1998, and from the IRBs of the University Teaching
Hospital in Antwerp and the Centre hospitalier affilie´ universitaire
de Que´bec in 2008.
Results
Overall, 2,112 men and women were recruited in 1998 and
2,507 in 2008. The majority of these subjects were female (52% in
1998 and 54% in 2008). In each study, 96.1% of the women
agreed to be interviewed whereas 89.3% (1998) and 87.4% (2008)
agreed to provide a venous blood sample. Among men 94.5%
(1998) and 91.2% (2008) accepted the interview while 85.9%
(1998) and 80.2% (2008) provided a venous blood sample. In
addition, 0.2% of women and men provided a DBS sample in
2008. Urine samples were provided by 85.7% (1998) and 88.4%
(2008) of the women and by 83.0% (1998) and 81.8% (2008) of the
men. In 2008, 1.4% of the women and 2.3% of the men were
tested for HIV on urine samples, with resulting proportions of
89.0% and 82.7% providing at least one biological sample (and
thus tested for HIV), respectively. The comparison of sexual
behaviour and socio-demographic characteristics between subjects
who were tested for HIV and those who did not showed a higher
proportion of subjects with no formal education among men not
tested for HIV: this difference was similar in both rounds (17.2%
versus 8.0% in 1998, p = 0.001; 18.8% versus 7.6% in 2008,
p,0.0001). Furthermore, in 1998, there was a higher proportion
of married subjects among men aged ,30 years not tested for
HIV compared to those who were tested (34.0% versus 13.8%,
p= 0.004), but this difference was not significant in 2008 (19.0%
versus 17.7%, p= 0.797) and for older men in either round (80.0%
versus 84.4% in 1998, p = 0.388; 78.4% versus 77.9% in 2008,
p = 0.938). Regarding the women, no significant difference
between tested and untested subjects was observed in either round
(data not shown).
The overall HIV prevalence was 3.4% in 1998 and 3.1% in
2008, but there were considerable differences by sex and age.
There was a significant decline in HIV among men (Figure 1 and
Table 1), that was more pronounced among those aged 15–
29 years (Figure 2), with a six-fold decrease, from 3.0 to 0.5%
(p= 0.002). There was also a decline in women aged 15–19 years,
but this was not significant (Figure 2). In the older age groups there
was an increase in HIV prevalence which was more pronounced
in women aged 30–49 years. Figure 1 also shows the prevalence of
other STIs in the two studies. Overall, the prevalence of syphilis
decreased significantly (p = 0.002, Figure 1C). The decrease in
syphilis was significant among women (p= 0.013, Figure 1A) and
borderline significant among men (0.097, Figure 1B). Among men,
there was a significant decrease in gonorrhea and a significant
increase in the prevalence of HSV-2 (p = 0.0001, Figure 1B).
There was also an overall increase in HSV-2 prevalence
(p = 0.008, Figure 1C). The changes in the prevalence of the
various STIs observed between the study rounds remained
significant in the multivariate analysis (Table 1).
Table 2 shows the changes in sociodemographic and behav-
ioural factors between the two study rounds. Nearly 90% of the
participants were sexually active and this proportion increased
between 1998 and 2008 only in women (p = 0.007). The
proportion of men and women who reported ever having used
condoms increased significantly over time, and it was higher in
men (61%) than in women (35%) in 2008. The proportion of
participants who reported commercial sex during the last year
increased significantly only in men. Irrespective of gender, the
proportion of subjects having attained a secondary educational
level or more increased significantly over time: from 3.8% to
20.4% among women (p,0.0001) and from 17.1% to 61.3%
among men (p,0.0001). Overall, men’s educational level was
higher than that of women in both surveys.
Figure 2. Multivariate comparison by age group of HIV prevalence between 1998 and 2008 among men and women, general
population of Cotonou, Benin. P-values are from Wald chi-square test from multivariate logistic models (taking into account the cluster affect and
adjusting for marital status). There is a significant decline in HIV prevalence in men aged 15–29 years and a non-significant decrease among women
aged 15–19 years. Irrespective of gender, there is a non-significant increase in HIV prevalence in all the other age groups. There were too few HIV-
infected men aged 15–19 years in both studies (zero in 1998 and only one in 2008) to further break down the 15–29 age group among men.
doi:10.1371/journal.pone.0043818.g002
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Table 2. Comparison of sociodemographic characteristics and sexual behaviour between 1998 and 2008 among women and men
aged 15–49 years, general population of Cotonou, Benin.
Demographic characteristics & sexual behaviour 1998 (N=2112) 2008 (N=2507) p-value{
Age [mean ± Standard error]
Women 28.1 (60.3) 28.6 (60.3) 0.240
Men 27.6 (60.3) 28.2 (60.3) 0.193
Overall 27.9 (60.2) 28.4 (60.2) 0.084
Marital status (%)
Women 0.0003
Married 600/1091 (55.0) 833/1340 (62.2)
Separated-Divorced-Widowed 93/1091 (8.5) 134/1340 (10.0)
Single 398/1091 (36.5) 373/1340 (27.8)
Men 0.158
Married 415/1018 (40.8) 482/1154 (41.8)
Separated-Divorced-Widowed 21/1018 (2.1) 40/1154 (3.5)
Single 582/1018 (57.2) 632/1154 (54.8)
Education level (%)
Women ,0.0001
None 409/1091 (37.5) 408/1343 (30.4)
Primary* 640/1091 (58.7) 661/1343 (49.2)
Secondary 34/1091 (3.1) 211/1343 (15.7)
University 8/1091 (0.7) 63/1343 (4.7)
Men ,0.0001
None 90/1018 (8.8) 100/1158 (8.6)
Primary 754/1018 (74.1) 348/1158 (30.1)
Secondary 116/1018 (11.4) 516/1158 (44.6)
University 58/1018 (5.7) 194/1158 (16.8)
Age at first sex [mean ± SE{]
Women 17.9 (60.1) 17.8 (60.1) 0.553
Men 17.8 (60.1) 17.8 (60.1) 0.789
Overall 17.9 (60.1) 17.8 (60.1) 0.577
Age at first marriage [mean ± SE{]
Women 20.5 (60.2) 21.8 (60.2) ,0.0001
Men 25.8 (60.3) 25.2 (60.2) 0.099
Overall 22.5 (60.2) 23.1 (60.2) 0.049
Sexually active [n/N (%)]
Women 950/1091 (87.1) 1220/1344 (90.8) 0.007
Men 892/1019 (87.5) 1032/1159 (89.0) 0.342
Overall 1842/2110 (87.2) 2252/2503 (90.0) 0.008
Ever used condom [n/N (%)]
Women 108/950 (11.4) 428/1220 (35.1) ,0.0001
Men 261/892 (29.3) 630/1032 (61.0) ,0.0001
Overall 369/1842 (20.0) 1058/2252 (47.0) ,0.0001
Paid or being paid for sex during the last year [n/N (%)]
Women 11/1093 (1.0) 18/1341 (1.3) 0.453
Men 67/1019 (6.6) 146/1159 (12.6) ,.0001
Overall 78/2112 (3.7) 164/2500 (6.6) ,.0001
Number of sexual partners during lifetime [mean ± SE{]
Women 2.3 (60.2) 2.4 (60.1) 0.481
Men 7.2 (60.5) 7.0 (60.4) 0.672
Overall 4.7 (60.3) 4.5 (60.2) 0.609
{p-value of Rao-Scott Chi-Square or t-test taking into account the cluster effect, {standard error, *completed or not.
doi:10.1371/journal.pone.0043818.t002
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Table 3. Risk factors for HIV infection using pooled data from the 1998 and 2008 surveys in the general population of Cotonou,
Benin.
Factor HIV prevalence n/N (%) Adjusted odds ratio (95% CI)& p-value
All subjects
Study round
Round 1 66/1939 (3.4) 1 –
Round 2 71/2288 (3.1) 0.95 (0.61–1.49) 0.8342
Age group
15–29 years 70/2610 (2.7) 1 –
30 years + 67/1617 (4.1) 1.00 (0.64–1.56) 0.9985
Educational level 0.0002{
None 45/899 (5.0) 1
Primary* 74/2227 (3.3) 0.72 (0.51–1.00)
Secondary or University** 18/1092 (1.7) 0.38 (0.23–0.65)
Marital status
Single 33/1851 (1.8) 1 –
Currently married 84/2104 (4.0) 1.76 (1.05–2.95) 0.0312
Divorced/Separated/Widowed 19/261 (7.3) 2.99 (1.56–5.73) 0.0010
Number of lifetime partners
,5 85/3092 (2.8) 1 –
$5 51/1127 (4.5) 2.12 (1.31–3.44) 0.0023
Women
Study round
Round 1 35/1013 (3.5) 1 –
Round 2 50/1239 (4.0) 1.23 (0.72–2.10) 0.4413
Age group
15–29 years 49/1377 (3.6) 1 –
30 years + 36/875 (4.1) 0.91 (0.54–1.51) 0.7006
Educational level 0.0080{
None 38/745 (5.1) 1
Primary* 41/1210 (3.4) 0.64 (0.41–1.02)
Secondary or University** 6/290 (2.1) 0.36 (0.15–0.88)
Marital status
Single 21/725 (2.9) 1 –
Currently married 48/1310 (3.7) 1.11 (0.58–2.11) 0.7629
Divorced/Separated/Widowed 16/210 (7.6) 2.17 (1.01–4.69) 0.0495
Number of lifetime partners
,5 67/2053 (3.3) 1 –
$5 17/193 (8.8) 2.70 (1.47–4.95) 0.0014
Men
Age effect in each study round1
Study round 1998
15–29 years 18/593 (3.0) 1 –
30 years + 13/333 (3.9) 0.48 (0.19–1.22) 0.1236
Study round 2008
15–29 years 3/640 (0.5) 1 –
30 years + 18/409 (4.4) 5.71 (1.21–26.92) 0.0277
Educational level 0.0524{
None 7/154 (4.6) 1
Primary* 33/1017 (3.2) 0.69 (0.31–1.56)
Secondary or University** 12/802 (1.5) 0.45 (0.20–1.05)
Marital Status
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In the multivariate analyses of risk factors for HIV infection,
there was a significant decrease in HIV prevalence across
increasing educational levels in women and all subjects combined,
whereas this decrease was borderline significant in men (Table 3).
Divorced separated and widowed men and women were more
likely to be HIV-positive. Married men also had a higher HIV
prevalence than single ones, whereas the prevalence was similar in
single and married women. There was a significant four-fold
higher HIV prevalence among women who reported having had
five lifetime sexual partners or more. In the men, the difference
was not significant.
In men, the interaction term between age and study round was
statistically significant (p = 0.0005). In 2008, there was a five-fold
higher HIV prevalence among men aged 30–49 years compared
to younger ones (Table 3), whereas age was not a significantly
associated with HIV in 1998. For women as well as for all subjects,
there was no significant statistical interaction between age and
study round (data not shown). Finally, no other significant
interaction was found between any of the other independent
variables and study round.
The variable ‘‘ever used condom’’ was not significantly
associated with HIV prevalence, although there was a tendency
towards a protective effect among men (HIV prevalence of 2.9%
among men reporting having ever used a condom vs. 4.2% among
the other ones, p = 0.2309).
Discussion
The major finding of this study is the significant decline in HIV
prevalence among young men aged 15–29 years from 1998 to
2008. Among women aged 15–19 years, there was a non-
significant decline. We did not assess HIV prevalence among
men aged 15–19 years as we did for women, since there were no
HIV-infected men in this age group in 1998, and only one in 2008.
Our findings are comparable to those of a study conducted in
Uganda in the 1990s which showed a significant decrease in HIV
prevalence in 13–24 year-old young men and a borderline decline
among women aged 13–19 years [23]. A significant decline
among men only was also observed more recently in repeated
national population-based surveys among young people aged 15–
24 years in South Africa and Tanzania [3,24].
In our study, there was a significant decrease in gonorrhea in
men, the latter being considered as a good marker for evaluating
recent sexual behavioural risk for HIV transmission [25]. Even if
the protective effect of having ever used a condom on HIV risk
was not statistically significant, the significant increase in condom
use between 1998 and 2008 has certainly played an important role
in the gonorrhea and HIV prevalence decline. The absence of a
significant association between having ever used a condom and
HIV prevalence could be related to the cross-sectional design of
the surveys that raised temporality issues. Indeed, people with
high-risk behaviour may start using condoms after becoming
aware of their risk of being HIV-positive [26]. Overall, the decline
in HIV prevalence among men was not associated with
noteworthy changes in sexual behaviour. In 2008, compared to
men aged .30 years, HIV prevalence was significantly lower in
the younger age group. The decrease in HIV prevalence in young
men happened while an intensive intervention targeting the sex
work milieu was ongoing. As shown by mathematical modelling
using data from Cotonou, reinforcement of preventive interven-
tions targeted at the sex work milieu can result in a significant
decrease in both the incidence and prevalence of HIV/STI in the
general population [16]. The intervention implemented in
Cotonou from 1992 onwards was strengthened between 2001
and 2006. During this period, 71% of the clients of FSWs were
aged 15–29 years, and it was estimated that 30% of the adult
males used commercial sex services during the previous year
[12,27]. Thus, the intervention may have reached more young
men aged 15–29 years than older ones. Overall, the men of the
general population may have been more extensively covered by
these preventive interventions than the women. Indeed, a higher
proportion of men reported condom use than women in both
rounds. There was also an increase in the proportion of men with
at least secondary education between the two study rounds. Our
results indicating a significant decreasing trend in HIV prevalence
across increasing educational levels are consistent with those of
previous studies in sub-Saharan Africa [28,29]. Educational
improvement, which is a distal determinant of HIV, is important
for a greater impact of preventive interventions on HIV risk
reduction and is therefore part of combination prevention
responses [30]. In our analyses, we thus made the choice to assess
the difference in HIV and STI prevalence over time without
adjusting for educational level. We indeed assumed that this factor
could not be considered as a confounder, but rather as an
intermediate factor that could have led, at least in part, to the
observed changes over time, especially given the huge increase in
educational level we observed between 1998 and 2008.
The national programme for access to ART began in Benin
only in 2002 and the proportion of treated subjects among those
eligible for ART increased from almost none in 1998 to 72% in
Table 3. Cont.
Factor HIV prevalence n/N (%) Adjusted odds ratio (95% CI)& p-value
Single 12/1126 (1.1) 1 –
Currently married 36/794 (4.5) 4.26 (1.93–9.39) 0.0003
Divorced/Separated/Widowed 3/51 (5.9) 4.76 (1.27–17.92) 0.0210
Number of lifetime partners
,5 18/1039 (1.7) 1 –
$5 34/934 (3.6) 1.29 (0.68–2.45) 0.4411
1The p-value for the interaction term between age and study round among men was 0.0005 (Llikelihood Ratio Test);
&95% confidence interval from multivariate logistic regression taking into account the cluster effect and additionally adjusted for sex in analyses of all subjects;
{p-value for trend in HIV prevalence across increasing educational levels, from logistic regression model adjusted for study round, age, marital status (and the
interaction term or the sex when applicable), and taking into account the cluster effect (using educational level as a continuous variable);
*completed or not;
**at least some level of secondary education.
doi:10.1371/journal.pone.0043818.t003
Decline in HIV Prevalence in Young Men
PLOS ONE | www.plosone.org 7 August 2012 | Volume 7 | Issue 8 | e43818
2008 [31]. Thus, the upward trend in HIV prevalence among the
oldest subjects is likely related, at least in part, to better survival
rates among those receiving ART. It has been noted that HIV
prevalence in young people can indirectly approximate HIV
incidence among them [24,32]. Accordingly, the proportion of
HIV-infected subjects with an advanced infection is likely to be
higher in older people. Thus, we can assume that in settings (like
Cotonou) where, during the study period, ART was initiated in
patients with advanced infection (CD4,200/mm3 or WHO
clinical stage 3 with CD4,350/mm3 or WHO stage 4 regardless
of CD4 cell count) [33], older people were more likely to be
treated. Because of such reasons, an increase in HIV prevalence of
3.6% in women and of 2.5% in men (30–34 year-olds) was
observed in South Africa in 2008 as a result of the impact of
successful antiretroviral therapy on improved survival [34].
Our data suggest an increase in the proportion of men who paid
for sex during the last year. Other studies suggest that the
proportion of men having sexual intercourse with FSWs may have
been under-reported in 1998 [35]. The observed increase could
thus be partially due to a decrease in the social desirability bias for
reporting this behaviour [36]. Nevertheless, risky sexual behaviour
is still prevalent as shown by the 2008 data.
In both men and women, being widowed/divorced/separated
was significantly associated with higher HIV prevalence. This has
also been observed in many other studies carried out in the general
population in developing countries [12,26]. Indeed, separated,
divorced and widowed women tend to be socially and culturally
isolated and are likely to be pressurised to meet the needs of their
family. Such women might be forced into situations which make
them vulnerable for sexual exploitation indirectly rendering them
vulnerable to HIV. On the other hand, their male counterparts
may get involved in risky sex to fulfill their sexual needs, as they do
not have a stable partner anymore. Finally, couple’s dissolution
and widowhood could also be related to HIV issues in one of the
partners (marital conflict because of HIV status, AIDS-related
death). While higher HIV prevalence among women was
associated with having more than five lifetime sexual partners,
this association was not significant in men. This result is similar to
that of a population-based study in 2005 in Coˆte d’Ivoire where
HIV prevalence was four-fold higher among women with six to
ten lifetime partners compared to women with only one, whereas
among men, no such association was observed [5]. Men have
more often a high number of sexual partners than women and
there is subsequently more heterogeneity of risk among them than
among the few women having a high number of partners, making
it more difficult to identify high number of sexual partners as a risk
factor for HIV among men.
The decline in NG prevalence among men could be related to
the positive impact of FSW preventive interventions as reported in
several studies [14,37]. In addition to the potential impact of FSW
interventions and increased educational level, the overall decline
in syphilis could be related in part to systematic screening and
treatment of this infection during antenatal visits [38], and also
during premarital check-ups which are now an encouraged
practice in Benin.
The observed increase in HSV-2 prevalence between the two
study rounds could be related to the fact that, during sexual
intercourse, condom use protects less against HSV-2 acquisition
than against HIV. In previous studies, consistent condom use has
been found to be associated with 30% and 80–96% reduction in
incidence of HSV-2 and HIV, respectively [39–41]. Continuous
risk taking combined with differences in the protective effective-
ness of condom use could explain why HSV-2 prevalence
increased in 2008 among men in general and in young men in
particular, in contrast to the decrease observed in HIV and
gonorrhoea prevalence. Moreover, the decrease in CD4 cell count
over time in HIV infected subjects may increase the risk of HSV-2
acquisition [42] and more frequent herpetic ulcers in HIV/HSV-2
co-infected subjects will increase the likelihood of onwards HSV-2
transmission [43]. It is therefore to be expected that HSV-2
prevalence increases as the HIV epidemic matures, since an
increasing proportion of HIV-infected subjects is at an advanced
stage of the disease [44]. Finally, since the Kalon test has been
shown to have a somewhat higher sensitivity than that of the Gull,
but a similar specificity, and given the previously-observed wide
variability in performance between HSV-2 specific antibody
detection tests [22,45], we cannot exclude the potential impact
of a change in testing method on the observed trend.
There are some methodological issues that could have impacted
on the validity of our results. Firstly, two different kits were used
for HIV confirmation (Capillus HIV1/2 in 1998 and Genie IIH in
2008); however the reported performances for both are similar
[46]. In addition, the HIV screening test used on urine samples of
a few subjects has a reported sensitivity of 100% and specificity of
98.7%; however the use of Western Blot confirmation enables the
elimination of false positive results [47]. It is therefore unlikely that
differences in the tests used between the two rounds are
responsible for the significant decline in HIV prevalence observed
in young men. Different tests for the confirmation of NG and CT
were also used between 1998 and 2008, but their reported
performances were similar and were then unable to artificially
induce the observed trends [48]. Secondly, we did not standardise
our comparisons on the basis of the differences in age distribution
between the two rounds. However, given a similar age distribution
in both rounds, this is very unlikely to have biased our analyses.
Thirdly, differential response rates in the two surveys could have
biased our analyses, but fortunately, we had high and comparable
participation rates in both rounds (for HIV testing, 85.9% in 1998
and 82.7% in 2008 among men, and corresponding figures of
respectively 89.3% and 89.0% among women). When comparing
subjects who gave a biological sample for HIV testing to those who
did not, there were few differences among men and no significant
ones among women. Non-response therefore seems unlikely to
have resulted in substantial overestimation of the decline in HIV
prevalence.
Finally, the information collected in 1998 was insufficient to
estimate the weights of the sampling units for analyses. However,
in both 1998 and 2008, the primary units were sampled based on a
‘‘probability proportional to size’’ method, and approximately the
same number of households were selected by segmentation of each
cluster. The samples can thus be considered as self-weighting
samples, unless response rates vary greatly between clusters or
study rounds. Since the response rates were high and similar
between rounds, it is unlikely that using unweighted logistic
regression could affect the validity of our results. We also adjusted
our analyses for the cluster effect to take into account a potential
type I error due to dependency between observations. Overall, we
thus conclude that our results are valid.
Conclusions
This is the first study that reports a significant decline in HIV
prevalence among young men in a sub-Saharan Africa country
where overall prevalence has never reached 5%. The decline
occurred when a preventive intervention targeting the sex work
milieu was ongoing and while the educational level was increasing.
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